CD24 and neoplasm: Though the impact of tumor cell‐associated CD24 on DC was not investigated in this study, previous work has shown that the CD24/Siglec‐10/G axis limits DC responsiveness to damage‐associated molecular patterns (DAMPs) including HMGB1, HSP70, and HSP90.37